Q/C Technologies, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Q/C Technologies, Inc. (QCLS) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 131.06% for the 0-month period ending 2022-07-07, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2024-04-01
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2016 was 95.02%, a 14.68% increase from fiscal 2015.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2015 was 82.86%, a 34.92% decline from fiscal 2014.
- Q/C Technologies, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2014 was 127.32%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|---|
| 2022-07-07 | 131.06% 10-Q · filed 2023-08-14 | 131.06% 10-K · filed 2024-04-01 | |||
| 2021-09-30 | 122.31% 10-Q/A · filed 2021-11-15 | ||||
| 2021-06-30 | 122.31% 10-Q · filed 2021-08-16 | ||||
| 2016-12-31 | 95.02% 10-K/A · filed 2018-07-13 | ||||
| 2016-09-30 | 93.08% 10-Q · filed 2016-11-14 | ||||
| 2015-12-31 | 82.86% 10-K · filed 2017-04-11 | ||||
| 2015-09-30 | 0.00% 10-Q · filed 2016-11-14 | ||||
| 2014-12-31 | 127.32% 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | 127.32% 10-Q · filed 2014-11-13 | ||||
| 2014-06-30 | 127.32% 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |